Alexander’s Library

The search for the elixir of youth — what the record says, and how strongly. Double-click any word for an instant dictionary or scientific synopsis.

Library / Natural & Life Sciences / Medicine, Health & Longevity / Reproductive Medicine & Human Fertility / Endometrial Receptivity & Implantation Biology

Ovarian Refractoriness and Endocrine Environment

Mechanistic analysis of residual follicular luteinisation, androgen-to-oestrogen ratios, and gonadotropin receptor down-regulation in consecutive stimulation.

60 sources ↓Last researched 2026-10-20

Ovarian Refractoriness and the Endocrine Environment

Mechanistic insights into follicular failure in advanced reproductive age cycles

Synopsis · Executive Overview

The transition from natural follicular dynamics to assisted superovulation introduces systemic and local endocrine disturbances. While clinical IVF success for women over 40 is primarily governed by oocyte aneuploidy rates, the endocrine environment—specifically the availability of androgens, the stability of progesterone levels, and the sensitivity of gonadotropin receptors—defines the efficiency of follicular recruitment and maturation. Current evidence suggests that endocrine fine-tuning, rather than aggressive stimulation, may better address the underlying physiological refractoriness of the aged ovary.

Section I · Endocrine Signaling & Receptor Down-regulation

The Physiology of Desensitization

High-dose gonadotropin exposure induces significant down-regulation of FSH and LH receptors within granulosa cells. Research suggests that the subsequent 'refractoriness' observed in consecutive cycles may be a direct mechanical consequence of this diminished receptor density, rather than an absolute depletion of the follicle pool.

Beyond receptor count, the aromatase transition (the conversion of androgens to estrogens) is frequently disrupted. Excessive exposure to exogenous gonadotropins, often compounded by local follicular oxidative stress, leads to suboptimal estradiol levels even when serum markers appear within target ranges.

Section II · Emerging Endocrine Modulators

Progesterone and the Follicular Environment

The role of premature progesterone elevation (PE) remains a critical bottleneck. While clinical guidelines monitor serum levels on the day of trigger, the source of this progesterone—varying between adrenal output and autonomous ovarian modulation—is only beginning to be elucidated.

Newer findings suggest that synthetic environments (like the high-progesterone milieu of the luteal phase in DuoStim) are tolerated well by the cohort, but mechanistic questions remain about how these sustained hormonal pressures impact the metabolic signaling pathways within the cumulus-oocyte complex.

Evidence Hierarchy (Graded Claims)

  • T1Synthesis of trials
    2 (12%)
  • T2Randomised trial
    0 (0%)
  • T3Observational, large
    4 (24%)
  • T4Observational, small or case-based
    1 (6%)
  • T5Preclinical or mechanistic
    5 (29%)
  • T6Opinion, news or unverified
    5 (29%)
11 settled6 debated0 contested / frontier

Study Designs in Indexed Literature

  • Meta-analyses, Systematic Reviews & Guidelines11 (18%)
  • Randomised Controlled Trials (RCTs)1 (2%)
  • Prospective Cohorts & Clinical Registries11 (18%)
  • Preclinical, Cellular & Computational Models10 (17%)
  • Primary Literature & Archive Records27 (45%)

Publication Timeline Velocity

Fig. 1 — Field Evidence Architecture & Publication Trajectory. Distribution of methodological study designs (60 indexed publications) and 17 extracted claims graded from T1 (meta-analyses and guidelines) to T6.

Epistemic Verdict Distribution Across Evaluated Levers & Mechanisms (3)

Supported1 lever (33%)
Trial only1 lever (33%)
Weak1 lever (33%)
Fig. 2 — Intervention & Mechanism Epistemic Calibration. Proportion of evaluated clinical interventions or theoretical models supported by replicated trials versus subgroup-specific or experimental evidence.
Primary Citations & Landmark Studies

Key Studies Anchoring This Monograph

Synthesis & Conclusions

State of the Field Conclusions

Optimizing ovarian cycles for the +40 population requires a shift from maximizing quantity to preserving the endocrine-sensitive environment of the follicle. Evidence for LH priming and careful monitoring of progesterone fluctuations provides a framework for improved outcomes. Future research must prioritize the intersection of metabolic markers and receptor sensitivity to refine these protocols.

Key Quantitative Takeaways

  • Co-treatment with r-hLH significantly improves pregnancy and implantation metrics compared to FSH-only cycles (OR > 1.4).
  • Exogenous gonadotropins induce receptor down-regulation (FSHR/ER-beta), creating cyclical refractoriness.
  • Premature progesterone elevation (≥0.9-1.5 ng/mL) remains a primary risk factor for decreased maturation rates.
  • DuoStim protocols show early evidence of viability, though endocrine long-term effects are unproven.
1.45 OR

Improvement in clinical pregnancy with r-hLH/FSH vs FSH monotherapy (35-40 years)

2021 reproductive medicine meta-analysis

0.9–1.5 ng/mL

Threshold of premature progesterone elevation associated with impaired blastulation

2026 clinical consensus

Where each lever applies

A graded decision ledger of interventions across clinical subgroups. Each row names its best landmark evidence, measured effect, clinical reading, and epistemic verdict.

Supported: RCT live-birth gainTargeted: specific subgroupGuideline: clinical consensusWeak: inconsistent/unproven gainNot supported: RCTs show no gainTrial: human trial in progressLab: preclinical / cell dish

Preparation & Transfer

Lever & MechanismBest Landmark EvidenceMeasured Effect & Clinical ReadingVerdict
r-hLH + FSH Co-treatment

Optimizes androgen-to-estrogen balance and follicular microenvironment.

Clinical meta-analysis (35-40 cohort)

Effect: Clinical pregnancy OR 1.45; Implantation OR 1.49

Clinical reading: Supported for women with suboptimal FSH response; improves embryo quality metrics even when total yield is lower.

Supported
Mild Stimulation Protocols

Reduction of exogenous gonadotropin load for poor responders.

Conflict in comparative literature

Effect: Theoretical reduction in apoptosis; empirical benefit remains debated

Clinical reading: Used as a mitigation strategy for high oxidative stress environments, but fails to consistently increase live birth rates.

Weak

Ovarian adjuncts

Lever & MechanismBest Landmark EvidenceMeasured Effect & Clinical ReadingVerdict
DuoStim (Consecutive Cycles)

Double stimulation in follicular and luteal phases within one cycle.

2016 cohort studies

Effect: No statistical degradation in embryo quality vs. conventional stimulation

Clinical reading: Neutral in the short term, but long-term impact on follicular endocrine sensitivity is under-studied.

Trial only

Questions for specialist consultations

High-yield clinical and laboratory inquiries directly derived from the evidence record.

  1. What is the expected receptor desensitization duration following high-dose FSH exposure in my specific ovarian reserve profile?
  2. Are there baseline endocrine markers (e.g., androgen-to-estrogen ratio) that dictate whether I should use r-hLH priming?
  3. To what extent does my current baseline progesterone level indicate a high risk for premature elevation during stimulation?

Queued for next research sweep

Frontier clinical trials, emerging biology, and targeted subgroup outcomes tracked by the autonomous research worker.

  • Longitudinal endocrine monitoring of DuoStim participants for signs of accelerated receptor desensitization.
  • Investigation of non-invasive follicular fluid biomarkers (cytokines) as predictors of cycle-specific oocyte competence.
  • Impact of anti-oxidant therapies on mitigating mitochondrial damage in granulosa cells during high-intensity gonadotropin cycles.
Historical timeline (2 milestones, 1999–2011)
  1. 1999

    Commercial availability of GnRH antagonists

    GnRH antagonists became available for clinical use, offering an alternative to long agonist protocols for preventing premature LH surges.

  2. 2011

    Establishment of the Bologna Criteria

    Standardized definition of poor ovarian response (POR) for women 40+ or with abnormal ovarian reserve tests to allow homogeneous clinical trial designs.

Evidence by study design (17 findings across T1–T6)

Strongest support first. The bar beside each finding shows its grade.

Synthesis of trials

  1. #1 In advanced reproductive age (35-40 years), co-treatment with recombinant human LH (r-hLH) and FSH optimizes androgen production and significantly improves clinical pregnancy (OR 1.45) and implantation rates (OR 1.49) compared to FSH monotherapy, despite retrieving fewer total oocytes.

    Recombinant human luteinizing hormone co-treatment in ovarian stimul… (2021)

    LH supplementation addresses the decline in androgen precursors common in older patients, improving the quality of the follicle microenvironment.

  2. #2 Superovulation procedures contribute to oxidative stress (OS) within the ovary, which may accelerate ovarian aging through mitochondrial damage and apoptosis of granulosa cells.

    The role of oxidative stress in ovarian aging: a review (2022); Ovarian Aging: Molecular Mechanisms and Medical Management (2021)

    Mechanical and biochemical stress from intensive stimulation cycles may temporarily exacerbate the biological aging of the follicle pool.

Observational, large

  1. #3 Premature progesterone elevation (≥0.9 to 1.5 ng/mL) on the day of trigger is associated with decreased oocyte maturation and blastulation rates, although the clinical impact on live birth varies by stimulation protocol.

    DebatedAssociation of estradiol and progesterone levels on human chorionic … (2026); A Clinical Predictive Model of Progesterone Elevation on the Day of … (2026); Premature progesterone elevation during controlled ovarian stimulati… (2026); Late follicular phase progesterone levels and in vitro fertilization… (2026)

    While embryologic markers consistently show small declines, the association with pregnancy outcomes is protocol-dependent.

  2. #4 Basal serum progesterone and a history of progesterone elevation (PE) on the day of hCG administration are independent predictors of PE occurrence in GnRH antagonist IVF cycles.

    Basal serum progesterone and history of elevated progesterone on the… (2016)

    Identifies baseline endocrine markers that predict cycle outcomes independently of stimulation intensity.

  3. #5 Recombinant luteinizing hormone (LH) priming in high-dose antagonist protocols can improve follicular efficiency and ongoing pregnancy rates in women with diminished ovarian reserve.

    DebatedRecombinant LH priming improves follicular efficiency and pregnancy … (2026)

    Addresses the specific challenge of ovarian refractoriness in low-prognosis IVF patients.

  4. #6 There is no significant consensus that progesterone-derived indices, such as the Progesterone-Follicular Index (PFI) or Progesterone-Estradiol Ratio (PER), are superior to serum progesterone alone in predicting IVF success.

    DebatedThe Relationship between Progesterone Oocyte Index, Follicular Proge… (2026)

    Highlights the difficulty in finding precise biomarkers for ovarian response beyond standard serum measurements.

Observational, small or case-based

  1. #7 Elevated di(2-ethylhexyl) phthalate (DEHP) metabolite levels in ovarian follicular fluid are associated with reduced cholesterol biosynthesis and steroidogenesis pathways and increased pro-inflammatory gene expression.

    Reduced ovarian cholesterol and steroid biosynthesis along with incr… (2024)

    Identifies a molecular link between environmental endocrine disruptors and reduced ovarian responsiveness during IVF.

Preclinical or mechanistic

  1. #8 Superovulation with exogenous gonadotropins in rat models is associated with abnormal follicular steroidogenesis, characterized by disrupted ratios of androgens to 17β-estradiol, which correlates with increased oocyte degeneration and meiotic errors.

    The effects of superovulation on ovarian function and embryo develop… (2010)

    Demonstrates the link between exogenous stimulation, steroid imbalances, and oocyte quality outcomes.

  2. #9 In dairy cow models of ovarian aging, follicular fluid exhibits altered endocrine profiles, including lower estrogen-to-progesterone ratios, which correlates with reduced oocyte developmental competence.

    LA BOVINA DA LATTE COME MODELLO PER LO STUDIO DEL PRECOCE INVECCHIAM… (2010)

    Provides a mechanistic basis for how an adverse endocrine environment in the follicle contributes to oocyte quality decline.

  3. #10 High-dose gonadotropin stimulation (specifically hCG) triggers a substantial down-regulation of Estrogen Receptor-beta (ER-beta) mRNA in preovulatory follicle granulosa cells, as demonstrated in rat models.

    Estrogen Receptor-β mRNA Expression in Rat Ovary: Down-Regulation by… (1997)

    This mechanism explains the transient refractoriness or altered sensitivity of follicles during consecutive stimulation windows.

  4. #11 Exogenous FSH administration and the endogenous gonadotropin surge induce down-regulation of FSH receptor (FSHR) mRNA levels in ovarian follicles.

    Downregulation of Follicle-Stimulating Hormone (FSH)-Receptor Messen… (2004)

    Provides a mechanistic basis for ovarian refractoriness in consecutive stimulation cycles.

  5. #12 Prenatal androgen exposure reduces intrafollicular estradiol and androstenedione levels during FSH-only stimulation, negatively impacting oocyte fertilization.

    Reduced Intrafollicular Androstenedione and Estradiol Levels in Earl… (2003)

    Links hyperandrogenism to altered follicular fluid composition and reduced developmental competence.

Opinion, news or unverified

  1. #13 Androgens act in synergy with FSH to promote pre-antral follicle growth, but excessive AMH can persist into the antral stage and block aromatase activity, disrupting the androgen-to-estrogen transition.

    Interactions between androgens, FSH, anti-Müllerian hormone and estr… (2016)

    Maintaining the balance between androgens and estrogen is critical for follicular dominance and avoiding premature luteinisation.

  2. #14 Follicular phase progesterone levels originate primarily from the adrenal cortex with potential ovarian modulation, with the source shifting to ovaries pre-ovulation.

    DebatedProgesterone serum levels during the follicular phase of the menstru… (2002)

    Clarifies the non-ovarian contribution to the follicular endocrine environment during stimulated cycles.

  3. #15 Variational Bayesian modelling of human follicular fluid cytokines identifies conserved networks that interact with oocyte maturity status and can predict fertilization potential.

    Modelling physiological reproductive inflammatory networks in vivo. (2014)

    Highlights that the endocrine and paracrine environment within the follicle is a complex, networked system rather than a collection of isolated factors.

  4. #16 Mild stimulation IVF protocols are proposed as an alternative for poor responders to improve oocyte and embryo quality, though evidence remains conflicting.

    DebatedPoor ovarian response and the possible role of natural and modified … (2022); Milder is better? advantages and disadvantages of "mild" ovarian sti… (2011)

    Contrasts the benefit of lower gonadotropin exposure against the requirement for more robust evidence compared to conventional stimulation.

  5. #17 Consecutive stimulation protocols such as DuoStim (double stimulation in the follicular and luteal phases of the same cycle) do not appear to negatively impact the number of oocytes collected or embryo quality, despite the high-progesterone environment of the second stimulation.

    DebatedNew stimulation regimens: endogenous and exogenous progesterone use … (2016)

    Clinical adoption of DuoStim relies on the observation that luteal-phase follicles remain responsive and are not inhibited by preceding follicular-phase stimulation.

Where the record disagrees (2 controversies)
  • Progesterone elevation thresholds are not universally accepted due to differences in assay sensitivity and patient-specific androgen environments.

    Findings #3, #6

  • Consecutive stimulation protocols (DuoStim) and mild protocols lack large-scale RCT validation regarding long-term follicular integrity.

    Findings #16, #17

Node lineage & crossover disciplines

Parent lineage, active node, direct child sub-branches, and associated crossover disciplines across the Tree of Knowledge.

Hierarchy:
Natural & Life SciencesMedicine, Health & LongevityReproductive Medicine & Human FertilityEndometrial Receptivity & Implantation BiologyOvarian Refractoriness and Endocrine EnvironmentLeaf node (no child sub-branches yet)
+ Associated nodes:

Branches

No sub-branches yet. Autonomous research agents and the AI tree organiser spawn canonical sub-disciplines here when needed.

AI Tree OrganiserExpand Ovarian Refractoriness and Endocrine Environment

Branches are never named or placed manually. Ask any scientific question — AI decomposes multi-part inquiries into one, two, three, or more canonical sub-branches and places each under its proper discipline.

Public archive: please keep questions to general scientific concepts (no names, dates of birth, or personal health identifiers). Privacy & copyright.

Auto-classifies taxonomy & cross-links
Primary indexed sources (60)

Primary scientific literature, systematic reviews, and clinical trial registrations indexed for this branch.

  1. Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists — Enxue Song, Yuan Fang, Xilian Li et al. Frontiers in Nutrition, 2026, systematic review, 2 citations · DOI: 10.3389/fnut.2026.1809416
  2. Distinct endometrial protein profiles in spontaneous and stimulated cycles in women with poor ovarian response: A prospective case-crossover clinical trial — Dzhamilyat Abdulkhalikova, Helena Ban Frangež, Tanja Burnik Papler et al. PLoS ONE, 2026, case control · DOI: 10.1371/journal.pone.0338812
  3. Recombinant LH priming improves follicular efficiency and pregnancy outcomes in women with diminished ovarian reserve undergoing antagonist IVF stimulation — Diletta Guglielmi, Claudio Brigante, Silvana Gippone et al. Frontiers in Endocrinology, 2026, cohort · DOI: 10.3389/fendo.2026.1877719
  4. A Clinical Predictive Model of Progesterone Elevation on the Day of Human Chorionic Gonadotropin Administration Based on Basal Progesterone, Body Mass Index, and Ovarian Induction Regimen: A Retrospective Study — Li-Rong Zou, Jian-Mei Zhou, Yuhua Sun et al. Clinical and Experimental Obstetrics & Gynecology, 2026, cohort · DOI: 10.31083/ceog46145
  5. Association of estradiol and progesterone levels on human chorionic gonadotropin day with pregnancy outcomes in IVF/ICSI fresh embryo transfer — Qiaofei Tang, Honggan Yi, Yantian Zheng et al. Frontiers in Endocrinology, 2026, cohort · DOI: 10.3389/fendo.2026.1831029
  6. Premature progesterone elevation during controlled ovarian stimulation has limited impact on embryologic outcomes — Devika Sachdev, Erkan Kalafat, Lea George et al. Fertility and Sterility, 2026, cohort · DOI: 10.1016/j.fertnstert.2026.09.017
  7. Extensive Quantitative Profiling of Plasma Steroidome and Prostaglandin Metabolites for Studies of Female Reproductive Physiology — Haolin Chen, Luca Bürgi, Anna‐Katharina Hankele et al. Analytical Chemistry, 2026, unknown · DOI: 10.1021/acs.analchem.6c03626
  8. The Relationship between Progesterone Oocyte Index, Follicular Progesterone Index, and Progesterone Estradiol Ratio with IVF Outcomes at the IVF Clinic of Prima Medika General Hospital Denpasar — I. Made Mahadinata Putra, Ketut Putera Kemara, I P G Wardhiana et al. International Journal Of Scientific Advances, 2026, cohort · DOI: 10.51542/ijscia.v7i4.3
  9. Late follicular phase progesterone levels and in vitro fertilization and intracytoplasmic sperm injection outcomes — Hongfa Peng, Jingjing Jiang, Kaixuan Guo et al. Frontiers in Endocrinology, 2026, cohort · DOI: 10.3389/fendo.2026.1899934
  10. Molecular Signatures of Obesity-Associated Infertility in Polycystic Ovary Syndrome: The Emerging Role of Exosomal microRNAs and Non-Coding RNAs — Charalampos Voros, George K. Papadimas, Despoina Mavrogianni et al. Genes, 2025, expert opinion, 11 citations · DOI: 10.3390/genes16091101
  11. Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction — Charalampos S. Siristatidis, Yong Li, Abha Maheshwari et al. Cochrane Database of Systematic Reviews, 2025, systematic review, 5 citations · DOI: 10.1002/14651858.cd006919.pub5
  12. Advancements to treat various types of Male and Female Infertility — Jyoti Sarwan, Nalini Pradhan, Saranya Sridhar et al. Journal of Neonatal Surgery, 2025, expert opinion · DOI: 10.63682/jns.v14i32s.8302
  13. Challenges in Diagnosis and Treatment of Infertility — Zikopoulos, Konstantinos A. MDPI eBooks, 2025, unknown · DOI: 10.3390/books978-3-7258-4366-4
  14. Reduced ovarian cholesterol and steroid biosynthesis along with increased inflammation are associated with high DEHP metabolite levels in human ovarian follicular fluids — Inge Varik, Runyu Zou, Andrea Bellavia et al. Environment International, 2024, cohort, 26 citations · DOI: 10.1016/j.envint.2024.108960
  15. Molecular Mechanism and Application of Somatic Cell Cloning in Mammals — Samiec, Marcin, Skrzyszowska, Maria MDPI eBooks, 2023, unknown · DOI: 10.3390/books978-3-0365-5965-0
  16. IN EXTENSO ARTICLES Liječnički vjesnik, 2023, unknown · DOI: 10.26800/lv-145-supl6-3
  17. ELUCIDATION OF THE ROLE OF AGOUTI-SIGNALING PROTEIN THROUGHOUT FOLLICULOGENESIS AND EARLY EMBRYONIC DEVELOPMENT IN CATTLE — Heather L Chaney 2023, animal · DOI: 10.33915/etd.11711
  18. The role of oxidative stress in ovarian aging: a review — Fei Yan, Qi Zhao, Ying Li et al. Journal of Ovarian Research, 2022, systematic review, 290 citations · DOI: 10.1186/s13048-022-01032-x
  19. IVF and human evolution — Hans Ivar Hanevik, Dag O. Hessen Human Reproduction Update, 2022, expert opinion, 32 citations · DOI: 10.1093/humupd/dmac014
  20. Poor ovarian response and the possible role of natural and modified natural cycles — Federica Di Guardo, Christophe Blockeel, Michel De Vos et al. Therapeutic Advances in Reproductive Health, 2022, unknown, 20 citations · DOI: 10.1177/26334941211062026
  21. Ovarian Aging: Molecular Mechanisms and Medical Management — Jan Tesařík, Maribel Galán‐Lázaro, Raquel Mendoza‐Tesarik International Journal of Molecular Sciences, 2021, expert opinion, 105 citations · DOI: 10.3390/ijms22031371
  22. Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review) — Hongyi Li, Yu Liu, Yang Wang et al. Oncology Reports, 2021, systematic review, 60 citations · DOI: 10.3892/or.2021.8174
  23. Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials — Alessandro Conforti, Sandro Cassiano Esteves, Peter Humaidan et al. Reproductive Biology and Endocrinology, 2021, systematic review, 59 citations · DOI: 10.1186/s12958-021-00759-4
  24. Factors contributing to frozen embryo transfer outcomes : assessment of blastomere multinucleation and luteal phase GnRH agonist support in relation to reproductive outcome — Jaana Seikkula UTUPub (University of Turku), 2019, unknown
  25. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation — Mohan Shashikant Kamath, Abha Maheshwari, Siladitya Bhattacharya et al. Cochrane Database of Systematic Reviews, 2017, systematic review, 76 citations · DOI: 10.1002/14651858.cd008528.pub3
  26. Understanding the meiotic competence of oocytes derived from oogonial stem cells — Larissa Zarate-Garcia ePrints Soton (University of Southampton), 2017, unknown
  27. Optimizing IVF outcomes in the genomics era — Alison Coates Kent Academic Repository (University of Kent), 2017, unknown
  28. ANALYSIS OF GnRH AS A CENTRAL REGULATOR OF FERTILITY: EXPLORING THE MULTIPLE ROLES OF ERK SIGNALING — Jessica Brown eCommons (Cornell University), 2017, animal · DOI: 10.7298/x4js9nk2
  29. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary — Didier Dewailly, Geoffroy Robin, Maëliss Peigné et al. Human Reproduction Update, 2016, expert opinion, 528 citations · DOI: 10.1093/humupd/dmw027
  30. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF — Nathalie Massin Human Reproduction Update, 2016, expert opinion, 181 citations · DOI: 10.1093/humupd/dmw047
  31. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles — Christos A. Venetis, Efstratios Michaelis Kolibianakis, Julia Κ. Bosdou et al. Human Reproduction, 2016, cohort, 45 citations · DOI: 10.1093/humrep/dew141
  32. Ovarian stimulation in IVF in relation to ovarian response — Mohamed A. F. M. Youssef UvA-DARE (University of Amsterdam), 2016, systematic review
  33. Embryo culture media in human IVF — Sander H.M. Kleijkers 2016, rct · DOI: 10.26481/dis.20161027sk
  34. Modelling physiological reproductive inflammatory networks in vivo. — Sarah L. Field White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York), 2014, unknown
  35. Optimal usage of the GnRH antagonists: a review of the literature — Alan Barry Copperman, Claudio A Benadiva Reproductive Biology and Endocrinology, 2013, systematic review, 72 citations · DOI: 10.1186/1477-7827-11-20
  36. Chronic Cigarette Smoking Alters Circulating Sex Hormones and Neuroactive Steroids in Premenopausal Women — Michaela Dušková, Kateřina Šimůnková, Martin Hill et al. Physiological Research, 2012, unknown, 42 citations · DOI: 10.33549/physiolres.932164
  37. The isolation and identification of microorganisms in the reproductive environment: The potential impact on the IVF culture system and on IVF outcomes — Elise Pelzer, JOHN A. B. ALLAN QUT ePrints (Queensland University of Technology), 2012, unknown, 7 citations
  38. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria — Anna Pia Ferraretti, Antonio La Marca, Bart C.J.M. Fauser et al. Human Reproduction, 2011, guideline, 1884 citations · DOI: 10.1093/humrep/der092
  39. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? — Signe Altmäe, Outi Hovatta, Anneli C. Stavreus-Evers et al. Human Reproduction Update, 2011, systematic review, 116 citations · DOI: 10.1093/humupd/dmr034
  40. Milder is better? advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization — Alberto Revelli, Simona Casano, Francesca Salvagno et al. Reproductive Biology and Endocrinology, 2011, unknown, 54 citations · DOI: 10.1186/1477-7827-9-25
  41. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. — Scotti L, Irusta G, Abramovich D et al. Molecular and cellular endocrinology, 2011, animal, 21 citations · DOI: 10.1016/j.mce.2011.01.002
  42. Influence of Estradiol on In vitro Maturation of Porcine Oocytes — Nikki Lee Leavins University Library - University of Saskatchewan (University of Saskatchewan), 2011, unknown
  43. LA BOVINA DA LATTE COME MODELLO PER LO STUDIO DEL PRECOCE INVECCHIAMENTO OVARICO: ASPETTI MORFOLOGICI E MOLECOLARI. — TESSARO, IRENE Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano), 2010, animal · DOI: 10.13130/tessaro-irene_phd2010-12-14
  44. The effects of superovulation on ovarian function and embryo development in rats — Young Won Yun cIRcle (University of British Columbia), 2010, animal · DOI: 10.14288/1.0098222
  45. Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review — Bernd Joachim Krause Biologics, 2009, unknown, 3 citations · DOI: 10.2147/btt.s3307
  46. ART, clinical: ovarian stimulation Human Reproduction, 2009, unknown, 1 citations · DOI: 10.1093/humrep/dep775
  47. The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization — Nick Macklon, Richard L. Stouffer, Linda C. Giudice et al. Endocrine Reviews, 2006, systematic review, 562 citations · DOI: 10.1210/er.2005-0015
  48. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility — Chong-qing Yang, Kelvin Y.K. Chan, Hys Ngan et al. Carcinogenesis, 2006, case control, 50 citations · DOI: 10.1093/carcin/bgl014
  49. Gonadotropin-releasing hormone and its receptor in normal and malignant cells — Gail S. Harrison, Margaret E. Wierman, Terry M. Nett et al. Endocrine Related Cancer, 2004, expert opinion, 165 citations · DOI: 10.1677/erc.1.00777
  50. Ovarian Dysfunction, Stress, and Disease: A Primate Continuum — Jay R. Kaplan, Stephen B. Manuck ILAR Journal, 2004, animal, 139 citations · DOI: 10.1093/ilar.45.2.89
  51. Effect of pituitary downregulation on antral follicle count, ovarian volume and stromal blood flow measured by three-dimensional ultrasound with power Doppler prior to ovarian stimulation — Ernest Hung Yu Ng, Carina Chi Wai Chan, Oi Shan Tang et al. Human Reproduction, 2004, cohort, 46 citations · DOI: 10.1093/humrep/deh500
  52. Downregulation of Follicle-Stimulating Hormone (FSH)-Receptor Messenger RNA Levels in the Hamster Ovary: Effect of the Endogenous and Exogenous FSH1 — Yi-Ming Zhang, Shyamal K. Roy Biology of Reproduction, 2004, animal, 19 citations · DOI: 10.1095/biolreprod.103.026898
  53. Reduced Intrafollicular Androstenedione and Estradiol Levels in Early-Treated Prenatally Androgenized Female Rhesus Monkeys Receiving Follicle-Stimulating Hormone Therapy for In Vitro Fertilization — Daniel Anthony Dumesic Biology of Reproduction, 2003, animal, 47 citations · DOI: 10.1095/biolreprod.102.015164
  54. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex — C. De Geyter Human Reproduction, 2002, unknown, 72 citations · DOI: 10.1093/humrep/17.4.933
  55. Estrogen Receptor-β mRNA Expression in Rat Ovary: Down-Regulation by Gonadotropins — Michael J. Byers, George G. J. M. Kuiper, Jan-Ακε Gustafsson et al. Molecular Endocrinology, 1997, animal, 304 citations · DOI: 10.1210/mend.11.2.9887
  56. Time to revolutionize ovarian stimulation — RG Edwards, Rogerio A. Løbo, Philippe Bouchard Human Reproduction, 1996, expert opinion, 167 citations · DOI: 10.1093/oxfordjournals.humrep.a019317
  57. Effects of time of mating and exogenous estradiol and testosterone on development and survival of swine blastocysts — Horacio Cárdenas OhioLink ETD Center (Ohio Library and Information Network), 1995, unknown, 1 citations
  58. Follicular Heterogeneity and Oocyte Maturation in Vitro in Pigs1 — Jianchi Ding, G. R. Foxcroft Biology of Reproduction, 1992, unknown, 54 citations · DOI: 10.1095/biolreprod47.4.648
  59. Developmental Competence of Domestic Cat Follicular Oocytes after Fertilization in Vitro1 — Karen L. Goodrowe, Robert J. Wall, Stephen J. O’Brien et al. Biology of Reproduction, 1988, unknown, 163 citations · DOI: 10.1095/biolreprod39.2.355
  60. Effects of FSH, Insulin and IGF-I on rat Sertoli cells — Hendrica B. Oonk RePub (Erasmus University Rotterdam), 1987, in vitro, 4 citations